Baird Maintains Outperform on Cardinal Health, Raises Price Target to $274
Cardinal Health, Inc.
Cardinal Health, Inc. CAH | 0.00 |
Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:
CAH) with a Outperform and raises the price target from $251 to $274.
